QBie™ Spotlight: Todos Med Ltd. (OTCQB: TOMDF)
What does TOMDF do?
Daniel Hirsch (IR Manager – OTCQB: TOMDF): “Our aim is to save lives by developing a revolutionary approach to early cancer detection through a novel blood based technology platform utilizing spectroscopic analysis aided by artificial intelligence.The company was founded in 2010 and is headquartered in Rehovot, Israel. The company’s proprietary and patented Total Biochemical Infrared Analysis (TBIA) cancer screening method is based on infrared spectroscopic analysis of peripheral blood components. The TBIA method is ISO 13485 approved and received CE approval following strong clinical results demonstrating high specificity and sensitivity. In addition, the TBIA method has three patents in the USA and two additional pending patents.”
What is the next big goal Todos Medical is trying to accomplish/what should we keep an eye out for?
Daniel Hirsch: “Todos Medical has completed several clinical trials. We look forward to sharing the results of our trials in the near future. Additionally we seek to develop strategic relationships in Europe which will eventually allow us to bring our product to market.”
Why did you join the OTCQB/go public?
Daniel Hirsch: “We joined the OTC as a beginning of our journey to eventually be listed on Nasdaq. While we are commencing with the process to begin sales in Europe (CE approved), we will need to raise additional funds to pursue FDA approval for sales in the United States.”
How can members of the microcap community help you?
Daniel Hirsch: “We are always looking to develop strategic relationships with other companies who share our vision to improve cancer screening to the general public.”
QBie™ Spotlight is a virtual “welcome interview” for new OTCQB companies. QBie™ Spotlight helps issuers that are new to the OTCQB connect with microcap industry professionals, for free! Learn more about the QBie™ Spotlight HERE.
Disclaimer/Forward Looking Statements:
This Website and its contents are not to be construed, under any circumstances, as an offer to sell or a solicitation to buy or effect transactions in any securities. No investment advice is provided or should be construed to be provided herein. This Website and its owners, employees and affiliates are not, nor do any of them claim to be, registered broker-dealers or registered investment advisors. This Website may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Such forward-looking statements of or concerning the companies mentioned herein are subject to numerous uncertainties and risk factors, including uncertainties and risk factors that may not be set forth herein, which could cause actual results to differ materially from those stated herein. Accordingly, user of this Website are cautioned not to place undue reliance on such forward-looking statements. This Website undertakes no obligation to update any forward-looking statements that may be contained herein.